Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Standard

Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis. / Ghazanfar, Misbah Noshela; Thomsen, Simon Francis.

I: Journal of Dermatological Treatment, Bind 30, Nr. 4, 2019, s. 387-388.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Harvard

Ghazanfar, MN & Thomsen, SF 2019, 'Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis', Journal of Dermatological Treatment, bind 30, nr. 4, s. 387-388. https://doi.org/10.1080/09546634.2018.1515465

APA

Ghazanfar, M. N., & Thomsen, S. F. (2019). Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis. Journal of Dermatological Treatment, 30(4), 387-388. https://doi.org/10.1080/09546634.2018.1515465

Vancouver

Ghazanfar MN, Thomsen SF. Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis. Journal of Dermatological Treatment. 2019;30(4):387-388. https://doi.org/10.1080/09546634.2018.1515465

Author

Ghazanfar, Misbah Noshela ; Thomsen, Simon Francis. / Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis. I: Journal of Dermatological Treatment. 2019 ; Bind 30, Nr. 4. s. 387-388.

Bibtex

@article{7c6c4d778740499e860c4ea3e53483ca,
title = "Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis",
abstract = "We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.",
keywords = "Omalizumab, combined biologic therapy, etanercept, CSU",
author = "Ghazanfar, {Misbah Noshela} and Thomsen, {Simon Francis}",
year = "2019",
doi = "10.1080/09546634.2018.1515465",
language = "English",
volume = "30",
pages = "387--388",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Taylor & Francis",
number = "4",

}

RIS

TY - JOUR

T1 - Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis

AU - Ghazanfar, Misbah Noshela

AU - Thomsen, Simon Francis

PY - 2019

Y1 - 2019

N2 - We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.

AB - We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.

KW - Omalizumab

KW - combined biologic therapy

KW - etanercept

KW - CSU

U2 - 10.1080/09546634.2018.1515465

DO - 10.1080/09546634.2018.1515465

M3 - Journal article

C2 - 30132352

VL - 30

SP - 387

EP - 388

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 4

ER -

ID: 227694325